<DOC>
	<DOCNO>NCT02238535</DOCNO>
	<brief_summary>To assess effectiveness synthetic analogue prostacyclin postembolic residual pulmonary hypertension .</brief_summary>
	<brief_title>Use Ventavis Patients With Postembolic Residual Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients pulmonary embolism undergone surgical treatment ( intravascular thrombolysis , catheter thrombus fragmentation ) Patients preserved thromboembolism pulmonary circulation system mean pressure pulmonary artery 25 mm Hg Patient sign inform consent . Mean pulmonary artery pressure surgical treatment le 25 mm Hg Age 75 year . Patients increase risk bleed include gastric ulcer 12 duodenal ulcer acute , hemorrhagic stroke . Severe coronary artery disease ( unstable angina , myocardial infarction within last 6 month ) . Acute heart failure CHF IV NYHA . Severe arrhythmia . Pregnancy , lactation . The presence severe diseases organ system may result death first year surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>